Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Dev Biol
2014 Mar 20;1554:36-48. doi: 10.1016/j.brainres.2014.01.036.
Show Gene links
Show Anatomy links
Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.
Obradović ALj
,
Joksimović S
,
Poe MM
,
Ramerstorfer J
,
Varagic Z
,
Namjoshi O
,
Batinić B
,
Radulović T
,
Marković B
,
Roth BL
,
Sieghart W
,
Cook JM
,
Savić MM
.
???displayArticle.abstract???
Enormous progress in understanding the role of four populations of benzodiazepine-sensitive GABAA receptors was paralleled by the puzzling findings suggesting that substantial separation of behavioral effects may be accomplished by apparently non-selective modulators. We report on SH-I-048A, a newly synthesized chiral positive modulator of GABAA receptors characterized by exceptional subnanomolar affinity, high efficacy and non-selectivity. Its influence on behavior was assessed in Wistar rats and contrasted to that obtained with 2mg/kg diazepam. SH-I-048A reached micromolar concentrations in braintissue, while the unbound fraction in brain homogenate was around 1.5%. The approximated electrophysiological responses, which estimated free concentrations of SH-I-048A or diazepam are able to elicit, suggested a similarity between the 10mg/kg dose of the novel ligand and 2mg/kg diazepam; however, SH-I-048A was relatively more active at α1- and α5-containing GABAA receptors. Behaviorally, SH-I-048A induced sedative, muscle relaxant and ataxic effects, reversed mechanical hyperalgesia 24h after injury, while it was devoid of clear anxiolytic actions and did not affect water-maze performance. While lack of clear anxiolytic actions may be connected with an enhanced potentiation at α1-containing GABAA receptors, the observed behavior in the rotarod, water maze and peripheral nerve injury tests was possibly affected by its prominent action at receptors containing the α5 subunit. The current results encourage further innovative approaches aimed at linking in vitro and in vivo data in order to help define fine-tuning mechanisms at four sensitive receptor populations that underlie subtle differences in behavioral profiles of benzodiazepine site ligands.
Arolfo,
Diazepam impairs place learning in the Morris water maze.
1991, Pubmed
Arolfo,
Diazepam impairs place learning in the Morris water maze.
1991,
Pubmed
Atack,
GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics.
2010,
Pubmed
Atack,
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.
2011,
Pubmed
Auta,
Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
2010,
Pubmed
Bester,
Changes in tactile stimuli-induced behavior and c-Fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush.
2000,
Pubmed
Bridge,
Nerve crush injuries--a model for axonotmesis.
1994,
Pubmed
Choudhary,
Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
1992,
Pubmed
Di Lio,
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
2011,
Pubmed
Drexler,
Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states.
2013,
Pubmed
Fischer,
Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.
2010,
Pubmed
,
Xenbase
Gill,
A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
2011,
Pubmed
Griebel,
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
2001,
Pubmed
Hammarlund-Udenaes,
Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
2010,
Pubmed
Kalvass,
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery.
2002,
Pubmed
Kasugai,
Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling.
2010,
Pubmed
Knabl,
Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice.
2009,
Pubmed
Knabl,
Reversal of pathological pain through specific spinal GABAA receptor subtypes.
2008,
Pubmed
Koh,
Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment.
2013,
Pubmed
Lippa,
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
2005,
Pubmed
,
Xenbase
Malan,
Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain.
2002,
Pubmed
McEown,
Α2 GABAA receptor sub-units in the ventral hippocampus and α5 GABAA receptor sub-units in the dorsal hippocampus mediate anxiety and fear memory.
2013,
Pubmed
Mercolini,
Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE.
2009,
Pubmed
Milić,
The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.
2012,
Pubmed
Mirza,
NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
2008,
Pubmed
Munro,
Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets.
2009,
Pubmed
Munro,
Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
2008,
Pubmed
Nickolls,
A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain.
2011,
Pubmed
Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed
Paul,
Selective distribution of GABA(A) receptor subtypes in mouse spinal dorsal horn neurons and primary afferents.
2012,
Pubmed
Popik,
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
2006,
Pubmed
,
Xenbase
Prut,
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.
2003,
Pubmed
Rabe,
The novel anxiolytic ELB139 displays selectivity to recombinant GABA(A) receptors different from diazepam.
2007,
Pubmed
Ramerstorfer,
The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes.
2010,
Pubmed
Read,
Assessing brain free fraction in early drug discovery.
2010,
Pubmed
Rudolph,
GABA-based therapeutic approaches: GABAA receptor subtype functions.
2006,
Pubmed
Rudolph,
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.
2011,
Pubmed
Savić,
The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.
2009,
Pubmed
Savić,
Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?
2010,
Pubmed
,
Xenbase
Sieghart,
Structure, pharmacology, and function of GABAA receptor subtypes.
2006,
Pubmed
Siemiatkowski,
Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment.
2000,
Pubmed
Skolnick,
Anxioselective anxiolytics: on a quest for the Holy Grail.
2012,
Pubmed
Watanabe,
GABA and GABA receptors in the central nervous system and other organs.
2002,
Pubmed